A study team headed by Gernot Längst (University of Regensburg) and Markus Meißner (LMU Munich) has made significant progress in understanding the gene regulation of the malaria pathogen.
Research into the genomes of malaria parasites opens the door to more potent, novel therapies.
The dynamic and variable levels of this parasite in asymptomatic individuals argue against the use of single-point tests for infection diagnosis.
A team at University of Erlangen–Nuremberg (FAU) develops drugs for the treatment of malaria
